Projects

“A really great program that has enabled several important contacts for our company and helped to grow as a entrepreneur.” Harri, Sartar Therapeutics
“Surgify received highly important expert advice and international networks from the SPARK Finland -program. This is the place-to-be for a starting medtech entrepreneur!”

 

SPARKees – our teams

See alumni teams
IndiviChip

Batch: Fall 2025

Automated microfluidic platform for activity-based screening of extracellular biomarkers

Contact person: Tiina Sikanen

    ICDx – Next-Generation Immunoassays for Hormone Diagnostics

    Batch: Fall 2025

    Highly sensitive and scalable immunoassay platform enabling accurate hormone testing for both centralized laboratories and future point-of-care applications

    Contact person: Teppo Hyytiä

      GenesMAP

      Batch: Fall 2025

      γPNA/MNAzyme as a new tool for rapid and sensitive gene detection in double-strand DNA

      Contact person: Hongbo Zhang

        Orca

        Batch: Spring 2025

        Modernizing computer-assisted joint replacement surgery with a novel camera-based system

        Contact person: Ville Pitkänen & Taneli Tikkakoski

          Brain-Informed

          Batch: Spring 2025

          From traditional to neurophysiology-guided stroke rehabilitation — we are creating a tool to individualize motor rehabilitation based on each patient's unique functional brain reserve.

          Contact person: Miikkael Salmi

            AdCab

            Batch: Spring 2025

            We are targeting pancreatic cancer's Achilles heel with a groundbreaking and novel mechanism

            Contact person: Tuuli Ranki & Firas Hamdan

              Upcycling organic waste with earthworms

              Batch: Spring 2025

              We use transgenic earthworms to turn organic waste into high-value proteins, e.g. antibodies.

              Contact person: Michael Jeltsch

                Kudos – Cellular Twins

                Batch: Spring 2025

                We aim to create AI models that can diagnose diseases and predict drug efficacy from early-phase histological biopsies based on cellular morphology, whilst avoiding the need for expensive and time-consuming drug assays.

                Contact person: Minttu Polso

                Symptonic

                Batch: Spring 2025

                Developing an AI algorithm to remotely detect and monitor health indicators through analysis of speech signals

                Contact person: Mikko Petäjä

                  B1 Coils

                  Batch: Spring 2025

                  Next generation radiofrequency coils to acquire more data from each MRI scan, enhancing diagnostic and treatment precision.

                  Contact person: Denis Le Bras

                  PreMet

                  Batch: Spring 2025

                  We develop a rapid, accurate, and predictive diagnostic platform for early-stage breast cancer and its metastasis.

                  Contact person: Nonappa

                    Stop Seizures

                    Batch: Spring 2025

                    Stop Seizures project aims to develop a novel drug with a unique drug target for treating Epilepsy.

                    Contact person: Ushanandini Mohanraj

                      MyNeuroCure

                      Batch: Fall 2024

                      A novel & ground-breaking drug therapy for ALS

                      Contact person: Merja Voutilainen

                      DropByeDrop

                      Batch: Fall 2024

                      Simplifying Glaucoma Care: Monthly Eyedrops for Improved Patient Compliance

                      Contact person: Stanislav Kalinin

                      BrainFeat

                      Batch: Fall 2024

                      AI-based rapid feature extraction transforming medical big brain data into usable format

                      Contact person: Harri Merisaari

                      AR4U

                      Batch: Fall 2024

                      Developing an augmented reality solution to empower elderly individuals to live longer, healthier, and more active lives in their own homes.

                      Contact person: Timo Niskanen

                      Cornea Sense

                      Batch: Fall 2024

                      Cornea Sense aims to improve cornea health diagnostic by directly measuring cornea hydration levels for better patient outcomes and treatment

                      Contact person: Anton Chernenko

                      Immobilization stand

                      Batch: Fall 2024

                      A stand that allows easier casting and better performance in limb procedures.
                      (Link in Finnish)

                      Contact person: Pekka Nätti

                      NeuroEye Insight

                      Batch: Spring 2024

                      Opportunistic Screening of Alzheimer's Disease Using Retinal Imaging

                      Contact person: Sebastian Högnabba

                      DepMYC

                      Batch: Spring 2024

                      Developing MYC-dependency targeting drugs to treat cancer

                      Contact person: Juha Klefström

                      PREPARE

                      Batch: Spring 2024

                      Development of powerful protein-based vaccine technologies
                      Spin-out to Innofend Oy

                      Contact person: Minna Hankaniemi

                      OxyBioStroke

                      Batch: Spring 2024

                      A blood test for fast track to stroke treatment

                      Contact person: Helike Lõhelaid

                      ERresQ

                      Batch: Spring 2024

                      Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases.
                      Spin-out to ERresQ Oy

                      Contact person: Vera Kovaleva

                      Im.Engine

                      Batch: Spring 2024

                      Pocket sized microscope that solves the challenges faced by research and diagnostic labs.

                      Contact person: Igor Shevkunov

                      KAJO Neurotechnologies

                      Batch: Fall 2023

                      Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery
                      Turned into a drug development project.

                      Contact person: Mikko Airavaara

                      TrueScreen

                      Batch: Fall 2023

                      A novel, non-invasive approach for cancer screening and diagnosis

                      Contact person: Andrew Erickson

                      NAVIGATOR

                      Batch: Fall 2023

                      Developing and new tumour-specific agent designed to diagnose and treat metastatic brain tumours.

                      Contact person: Pirjo Laakkonen

                      Solid-IO

                      Batch: Fall 2023

                      Cancer immunotherapy testing on a chip.
                      Spin-out to Solid Immuno-Oncology Oy

                      Contact person: Heidi Haikala

                      MIOR Immunotherapy

                      Batch: Spring 2023

                      Developing new immunotherapies for cancer

                      Contact person: Carlos Rogerio Figueiredo

                      Immunoliposomes

                      Batch: Spring 2023

                      Immunoliposomes to detect rupture prone intracranial aneurysms

                      Contact person: Behnam Rezai Jahromi

                      Feanalytic

                      Batch: Spring 2023

                      Non-invasive method to diagnose intestinal diseases

                      Contact person: Lauri Polari

                      Vit3DAct

                      Batch: Spring 2023

                      Intra-articular calcipotriol for treatment of (osteo)arthritis

                      Contact person: Johanna Huhtakangas

                      Natal Mind

                      Batch: Spring 2023

                      Digital therapeutics treatment for fear of childbirth

                      Contact person: Annika Järvelin

                      Colorific

                      Batch: Spring 2023

                      DNA Nanoswitches-enabled Visual Colorimetric Diagnostics

                      Contact person: Jacky Loo

                      Glue4Life

                      Batch: Spring 2023

                      Next-generation bioinks for 3D bioprinting living tissues and organs.
                      Spin-out to LifeGlue Technologies Oy

                      Contact person: Anni Mörö

                      SanguID

                      Batch: Spring 2023

                      Improved early-stage cancer detection and sensitive disease monitoring
                      Project manager moved to University of Zurich.

                      Contact person: Pyry Helkkula

                      OTOS

                      Batch: Spring 2023

                      Early intervention for hearing health
                      Spin-out to Otos Health Oy

                      Contact person: Tanja Tervonen

                      INGA

                      Batch: Spring 2023

                      Novel method for optimized and personalized labor induction care

                      Contact person: Hanna Castrén-Niemi

                      Jedi BF R2B

                      Batch: Fall 2022

                      A smart optical sensor for arthroscopic surgery
                      Preparing spin-out to a startup.

                      Contact person: Isaac Afara

                      Mukava

                      Batch: Fall 2022

                      Graphene based dry electrodes for biometric measurements
                      Spin-out to Mukava Biosignals Oy

                      Contact person: Teemu Ruotsalainen

                      R2therapies

                      Batch: Fall 2022

                      Novel biomarker and early drug intervention for Alzheimer's disease

                      Spin-out to R2therapies Oy

                      Contact person: Ilkka Fagerlund

                        Surgerix

                        Batch: Fall 2022

                        (Former ER4Surgery) Image-guided surgery without Instruments.
                        Spin out to Surgerix Oy.

                        Contact person: Mikko Pitkänen

                        3D CelluGel

                        Batch: Fall 2022

                        A Novel Cell Growth Matrix by 3D Printing of Biopolymers

                        Contact person: Chunlin Xu

                        L-Cell

                        Batch: Spring 2022

                        Light- reconfigurable substrate for cell cultures

                        Contact person: Chiara Fedele

                        Brightlife

                        Batch: Spring 2022

                        Mental health platform and services

                        Spin-out to Brightlife Oy

                        Contact person: Eero Haikonen

                        COMITELL

                        Batch: Spring 2022

                        Delivery of encapsulated mitochondria as novel pharmaceutical solution

                        Contact person: Hongbo Zhang

                        Multivision Diagnostics

                        Batch: Spring 2022

                        Automated and scalable tool for precision diagnosis and personalized treatment
                        Spin-out to MultivisionDx Oy

                        Contact person: Karolina Punovuori

                        AIDHEART

                        Batch: Fall 2021

                        AI for the detection of heart transplant rejection.
                        Product validation continues, spin-out under consideration.

                        Contact person: Juha Peltonen

                        PAMO

                        Batch: Fall 2021

                        Novel method for diagnosing respiratory suppression
                        Spin-out to a non-published startup.

                        Contact person: Antti Vehkaoja

                        hentoTouch

                        Batch: Fall 2021

                        Non-invasive solution to support rehabilitation from AUD.
                        Spin-out to AlionLife Oy

                        Contact person: Jukka Planman

                        Urisens

                        Batch: Fall 2021

                        Diaper embedded biosensor platform, that screens abnormal clinical conditions

                        Contact person: Oguz Tanzer

                        Nosore

                        Batch: Fall 2021

                        Prevention of pressure ulcers
                        Manager was recruited as Team Leader to Attendo.

                        Contact person: Nuno Nobre

                        OrganAnalytics

                        Batch: Fall 2021

                        Viability analysis of organ transplants, and neuronal and cardiac implants
                        Preparing spin-out to a startup.

                        Contact person: Jarno Tanskanen

                        TumorMimic

                        Batch: Fall 2021

                        TumorMimic tailors 3D cultures to enable enhanced cancer drug screening

                        Contact person: Juho Pokki

                        GLOBEVAC

                        Batch: Fall 2021

                        How to make vaccines thermostable
                        Preparing to spin-out a startup.

                        Contact person: Manlio Fusciello

                        Proteabs

                        Batch: Spring 2021

                        Rapid diagnostics of human picornaviruses based on viral proteases

                        Contact person: Petri Susi

                        3DFluoHisto

                        Batch: Spring 2021

                        Novel method for histology.
                        Solution for commercial use at University of Turku.

                        Contact person: Ilkka Paatero

                        mTMS

                        Batch: Spring 2021

                        mTMS – multilocus transcranial magnetic stimulation.
                        Devices already in use at international pilot customers.

                        Contact person: Dubravko Kicic

                        Corflux

                        Batch: Spring 2021

                        Personalized prediction of the risk for aortic dilatation and rupture.
                        Preparing spin-out to a startup.

                        Contact person: Marja Hedman

                        JasminePro

                        Batch: Spring 2021

                        Poly(jasmine lactone): A Versatile Platform for Drug Delivery

                        Contact person: Kuldeep Bansal

                        MAIJU

                        Batch: 2020

                        Method for objective assessment of infant motor development.
                        Solution in use at BABA Center (HUS) and collaboration with Movesense.

                        Contact person: Sampsa Vanhatalo

                        DecoDerma

                        Batch: 2020

                        Tissue specific therapy for skin diseases.
                        Licensed to THERAVIA.

                        Contact person: Tero Järvinen

                        Integrated Secretion Solutions

                        Batch: 2020

                        Platform for optimized production of biotechnological proteins

                        Spin-out to Avenue Biosciences Oy and a startup in the U.S.

                        Contact person: Ville Paavilainen

                        MEG-MRI

                        Batch: 2020

                        Functional brain imaging reshaped

                        Contact person: Marko Havu

                        Wittify

                        Batch: 2020

                        Smart heart monitoring.

                        Spin-out to Sonai Health Oy.

                        Contact person: Arto Kotimaa

                        EpiHeart

                        Batch: 2020

                        Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.

                        Spin-out to EpiHeart Oy.

                        Contact person: Kai Kronström

                        AccuQT

                        Batch: 2020

                        Accurate correction for QT interval ‒ the most important cardiac risk measure.
                        Spin-out to Monicardi Oy

                        Contact person: Esa Räsänen

                        Capsamedix

                        Batch: 2020

                        Long-term oral drug delivery.

                        Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).

                        Contact person: Helder Santos

                        Anison

                        Batch: 2020

                        Natural medication for human papillomavirus (HPV)-associated warts.

                        Spin-out to ATB Antivirals Oy (previously Anison Therapeutics)

                        Contact person: Preethy Paul

                        Moncyte

                        Batch: 2020

                        Functional insight into hypercholesterolemia patients.
                        Spin-out to Moncyte Oy

                        Contact person: Simon Pfisterer

                        Algoa Progress

                        Batch: 2020

                        Personalized treatment planning of osteoarthritis.

                        Spin-out to MSK Technologies Oy.

                        Contact person: Joona Kemppainen

                        Solving the Mesh

                        Batch: 2020

                        Implantable support to treat pelvic organ prolapse.
                        Spin-out to Lignum Medical Oy

                        Contact person: Eija Raussi-Lehto

                        TOXELEGANS

                        Batch: 2020

                        Indoor air diagnostics with fluorescent C. elegans nematodes.

                        Lead to a co-research project.

                        Contact person: Päivi Koskinen

                        StemSight

                        Batch: 2019

                        Novel treatment for limbal epithelial stem cell deficiency.

                        Spin-out to StemSight Oy

                        Contact person: Laura Koivusalo

                        VIRI

                        Batch: 2019

                        Therapeutics for antimicrobial resistant bacteria.

                        Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.

                        Contact person: Christopher Jonkergouw

                        FRACTAID

                        Batch: 2019

                        Distal radius fractures artificial intelligence diagnostic tool.
                        Preparations for a startup in progress.

                        Contact person: Jorma Ryhänen

                        AdvaNeedle

                        Batch: 2019

                        Ultrasound solution for cancer biopsies
                        Technology licensing under preparation.

                        Contact person: Jouni Rantanen

                        DropPen

                        Batch: 2019

                        Simple droplet devices for biomedicine, diagnostics and pharma.
                        Got continuing development funding.

                        Contact person: Päivi Saavalainen

                        VertiGoggles

                        Batch: 2019

                        Vertigo diagnostics for primary care.

                        Got remarkable funding for another project.

                        Contact person: Tuomas Hyytiä

                        NADMed

                        Batch: 2019

                        Diagnostic test for vitamin B3 metabolism deficiency.

                        Spin-out to NADMED Oy

                        Contact person: Liliya Euro

                        TopoCoating

                        Batch: 2019

                        Topographically tuned and sustainable surfaces for biological applications.

                        Potential licensing case. Project manager got recruited as Innovation Manager at UTU.

                        Contact person: Erik Niemelä

                        Liquid Biopsy Solutions

                        Batch: Fall 2018

                        Laboratory and computational method for liquid biopsies.
                        Spin-out to Genomill Health Oy

                        Contact person: Manu Tamminen

                        PPI Modulators

                        Batch: Fall 2018

                        Rational discovery of protein-protein interaction modulators.

                        Spin-out to Aurlide Oy

                        Contact person: Olli Pentikäinen

                        PARKS – Parkinson’s Biomarker Test

                        Batch: Fall 2018

                        Parkinson’s signature biomarker assay.
                        Ongoing large validation study with Michael J Fox Foundation funding.

                        Contact person: Eleanor Coffey

                        LightReactor

                        Batch: Spring 2018

                        Light controlled protein production.
                        An alumni due Project Manager got recruited to Bayer.

                        Contact person: Jari Rossi

                        Team Scheperjans

                        Batch: Spring 2018

                        Microbiome therapy for Parkinson’s disease.
                        IP turned into NeuroBiome Oy that has contract with a large company

                        Contact person: Filip Scheperjans

                        HemoCure

                        Batch: Spring 2018

                        Extra cellular vesicle solution for bleeding disorders.
                        An alumni due Project Manager got recruited to Mayo Clinic (USA).

                        Contact person: Mayank Saraswat

                        FastEV

                        Batch: Spring 2018

                        Method for extra-cellular vesicle (EV) isolation.
                        Solution in use at EV group at University of Helsinki.

                        Contact person: Maija Puhka

                        Heart4Oxygen

                        Batch: Spring 2018

                        Method to monitor the oxygenation of myocardial tissue.
                        Spin-out to SpectroCor Oy

                        Contact person: Kalle Kotilahti

                        Maculaser

                        Batch: Spring 2018

                        Novel heat treatment for age related macular degeneration.
                        Spin-out to Maculaser Oy

                        Contact person: Jani Tirronen

                        Team Scheperjans

                        Batch: Spring 2018

                        Microbiome diagnostics for Parkinson’s disease.
                        IP turned to NeuroBiome Oy that has joint development and licensing agreement.

                        Contact person: Filip Scheperjans

                        TB Biofilm

                        Batch: Spring 2018

                        Mycobacterial biofilms as anti-tuberculosis drug targets.
                        Became a cornerstone of an extensive multinational research program.

                        Contact person: Mataleena Parikka

                        SCELLOMICS

                        Batch: Spring 2018

                        Novel single cell omics methods.
                        Spin-out to Scellex Oy

                        Contact person: Päivi Saavalainen

                        LASU

                        Batch: Spring 2018

                        Light-activated antimicrobial surfaces and materials.
                        IP acquired by Plasmonics Oy

                        Contact person: Alexandre Efimov

                        NEXTCAST

                        Batch: Fall 2017

                        AI solution for toxicity testing.

                        Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                        Contact person: Dario Greco

                        EyeLase

                        Batch: Fall 2017

                        Laser solution for eye treatment.

                        Became a development case for industry.

                        Contact person: Jukka Viheriälä

                        HuManCardio

                        Batch: Fall 2017

                        Toxicity test for heart cells.

                        Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                        Contact person: Tuula Heinonen

                        Olfactomics

                        Batch: Fall 2017

                        Tissue analysis for breast cancer surgery.
                        Spin-out to Olfactomics Oy

                        Contact person: Antti Roine

                        Ocular Surface Precision Panel

                        Batch: Spring 2017

                        Ocular biomarker panel and analysis.
                        Project manager got recruited to another project.

                        Contact person: Ulla Aapola

                        GreenSeq/ Seqnom

                        Batch: Spring 2017

                        Microbiological Analyses on (Blue) Bio- and Circular Economies.
                        Spin-out to GreenSeq Oy

                        Contact person: Kirsi-Maarit Lehto

                        SMART PD

                        Batch: Spring 2017

                        Peritoneal diagnostics for dialysis patients.
                        Spin-out to Kiwecare / Smart PD Solutions Oy

                        Contact person: Pirgit Silvast-Äikäs

                        SEBI-Group

                        Batch: Pilot 2016 / Spring 2017

                        Nano structure for bioimaging.
                        Spin-out to XFold Imaging Oy

                        Contact person: Timo Jäntti

                        Sartar

                        Batch: Pilot 2016 / Spring 2017

                        Cancer drug for GIST.
                        Spin out to Sartar Therapeutics Oy

                        Contact person: Harri Sihto

                        iDenta

                        Batch: Pilot 2016 / Spring 2017

                        Caries and infection prevention and treatment.

                        Spin-out to Koite Health Oy

                        Contact person: Tommi Pätilä

                        Surgify

                        Batch: Pilot 2016 / Spring 2017

                        Safety mechanism for surgical drills.

                        Spin-out to Surgify Medical Oy

                        Contact person: Visa Sippola

                        Alumni

                        Team Scheperjans

                        Batch: Spring 2018

                        Microbiome therapy for Parkinson’s disease.
                        IP turned into NeuroBiome Oy that has contract with a large company

                        Contact person: Filip Scheperjans

                        Olfactomics

                        Batch: Fall 2017

                        Tissue analysis for breast cancer surgery.
                        Spin-out to Olfactomics Oy

                        Contact person: Antti Roine

                        SEBI-Group

                        Batch: Pilot 2016 / Spring 2017

                        Nano structure for bioimaging.
                        Spin-out to XFold Imaging Oy

                        Contact person: Timo Jäntti

                        iDenta

                        Batch: Pilot 2016 / Spring 2017

                        Caries and infection prevention and treatment.

                        Spin-out to Koite Health Oy

                        Contact person: Tommi Pätilä

                        Surgify

                        Batch: Pilot 2016 / Spring 2017

                        Safety mechanism for surgical drills.

                        Spin-out to Surgify Medical Oy

                        Contact person: Visa Sippola

                        Liquid Biopsy Solutions

                        Batch: Fall 2018

                        Laboratory and computational method for liquid biopsies.
                        Spin-out to Genomill Health Oy

                        Contact person: Manu Tamminen

                        PPI Modulators

                        Batch: Fall 2018

                        Rational discovery of protein-protein interaction modulators.

                        Spin-out to Aurlide Oy

                        Contact person: Olli Pentikäinen

                        LightReactor

                        Batch: Spring 2018

                        Light controlled protein production.
                        An alumni due Project Manager got recruited to Bayer.

                        Contact person: Jari Rossi

                        HemoCure

                        Batch: Spring 2018

                        Extra cellular vesicle solution for bleeding disorders.
                        An alumni due Project Manager got recruited to Mayo Clinic (USA).

                        Contact person: Mayank Saraswat

                        SCELLOMICS

                        Batch: Spring 2018

                        Novel single cell omics methods.
                        Spin-out to Scellex Oy

                        Contact person: Päivi Saavalainen

                        EyeLase

                        Batch: Fall 2017

                        Laser solution for eye treatment.

                        Became a development case for industry.

                        Contact person: Jukka Viheriälä

                        SMART PD

                        Batch: Spring 2017

                        Peritoneal diagnostics for dialysis patients.
                        Spin-out to Kiwecare / Smart PD Solutions Oy

                        Contact person: Pirgit Silvast-Äikäs

                        Sartar

                        Batch: Pilot 2016 / Spring 2017

                        Cancer drug for GIST.
                        Spin out to Sartar Therapeutics Oy

                        Contact person: Harri Sihto

                        VertiGoggles

                        Batch: 2019

                        Vertigo diagnostics for primary care.

                        Got remarkable funding for another project.

                        Contact person: Tuomas Hyytiä

                        FastEV

                        Batch: Spring 2018

                        Method for extra-cellular vesicle (EV) isolation.
                        Solution in use at EV group at University of Helsinki.

                        Contact person: Maija Puhka

                        Heart4Oxygen

                        Batch: Spring 2018

                        Method to monitor the oxygenation of myocardial tissue.
                        Spin-out to SpectroCor Oy

                        Contact person: Kalle Kotilahti

                        Maculaser

                        Batch: Spring 2018

                        Novel heat treatment for age related macular degeneration.
                        Spin-out to Maculaser Oy

                        Contact person: Jani Tirronen

                        TB Biofilm

                        Batch: Spring 2018

                        Mycobacterial biofilms as anti-tuberculosis drug targets.
                        Became a cornerstone of an extensive multinational research program.

                        Contact person: Mataleena Parikka

                        LASU

                        Batch: Spring 2018

                        Light-activated antimicrobial surfaces and materials.
                        IP acquired by Plasmonics Oy

                        Contact person: Alexandre Efimov

                        HuManCardio

                        Batch: Fall 2017

                        Toxicity test for heart cells.

                        Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                        Contact person: Tuula Heinonen

                        Ocular Surface Precision Panel

                        Batch: Spring 2017

                        Ocular biomarker panel and analysis.
                        Project manager got recruited to another project.

                        Contact person: Ulla Aapola

                        GreenSeq/ Seqnom

                        Batch: Spring 2017

                        Microbiological Analyses on (Blue) Bio- and Circular Economies.
                        Spin-out to GreenSeq Oy

                        Contact person: Kirsi-Maarit Lehto

                        EpiHeart

                        Batch: 2020

                        Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.

                        Spin-out to EpiHeart Oy.

                        Contact person: Kai Kronström

                        Capsamedix

                        Batch: 2020

                        Long-term oral drug delivery.

                        Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).

                        Contact person: Helder Santos

                        Anison

                        Batch: 2020

                        Natural medication for human papillomavirus (HPV)-associated warts.

                        Spin-out to ATB Antivirals Oy (previously Anison Therapeutics)

                        Contact person: Preethy Paul

                        Algoa Progress

                        Batch: 2020

                        Personalized treatment planning of osteoarthritis.

                        Spin-out to MSK Technologies Oy.

                        Contact person: Joona Kemppainen

                        StemSight

                        Batch: 2019

                        Novel treatment for limbal epithelial stem cell deficiency.

                        Spin-out to StemSight Oy

                        Contact person: Laura Koivusalo

                        TopoCoating

                        Batch: 2019

                        Topographically tuned and sustainable surfaces for biological applications.

                        Potential licensing case. Project manager got recruited as Innovation Manager at UTU.

                        Contact person: Erik Niemelä

                        Team Scheperjans

                        Batch: Spring 2018

                        Microbiome diagnostics for Parkinson’s disease.
                        IP turned to NeuroBiome Oy that has joint development and licensing agreement.

                        Contact person: Filip Scheperjans

                        NEXTCAST

                        Batch: Fall 2017

                        AI solution for toxicity testing.

                        Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                        Contact person: Dario Greco

                        Wittify

                        Batch: 2020

                        Smart heart monitoring.

                        Spin-out to Sonai Health Oy.

                        Contact person: Arto Kotimaa

                        Solving the Mesh

                        Batch: 2020

                        Implantable support to treat pelvic organ prolapse.
                        Spin-out to Lignum Medical Oy

                        Contact person: Eija Raussi-Lehto

                        TOXELEGANS

                        Batch: 2020

                        Indoor air diagnostics with fluorescent C. elegans nematodes.

                        Lead to a co-research project.

                        Contact person: Päivi Koskinen

                        VIRI

                        Batch: 2019

                        Therapeutics for antimicrobial resistant bacteria.

                        Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.

                        Contact person: Christopher Jonkergouw

                        FRACTAID

                        Batch: 2019

                        Distal radius fractures artificial intelligence diagnostic tool.
                        Preparations for a startup in progress.

                        Contact person: Jorma Ryhänen

                        AdvaNeedle

                        Batch: 2019

                        Ultrasound solution for cancer biopsies
                        Technology licensing under preparation.

                        Contact person: Jouni Rantanen

                        DropPen

                        Batch: 2019

                        Simple droplet devices for biomedicine, diagnostics and pharma.
                        Got continuing development funding.

                        Contact person: Päivi Saavalainen

                        NADMed

                        Batch: 2019

                        Diagnostic test for vitamin B3 metabolism deficiency.

                        Spin-out to NADMED Oy

                        Contact person: Liliya Euro

                        PARKS – Parkinson’s Biomarker Test

                        Batch: Fall 2018

                        Parkinson’s signature biomarker assay.
                        Ongoing large validation study with Michael J Fox Foundation funding.

                        Contact person: Eleanor Coffey

                        Brightlife

                        Batch: Spring 2022

                        Mental health platform and services

                        Spin-out to Brightlife Oy

                        Contact person: Eero Haikonen

                        Integrated Secretion Solutions

                        Batch: 2020

                        Platform for optimized production of biotechnological proteins

                        Spin-out to Avenue Biosciences Oy and a startup in the U.S.

                        Contact person: Ville Paavilainen

                        MEG-MRI

                        Batch: 2020

                        Functional brain imaging reshaped

                        Contact person: Marko Havu

                        KAJO Neurotechnologies

                        Batch: Fall 2023

                        Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery
                        Turned into a drug development project.

                        Contact person: Mikko Airavaara

                        Natal Mind

                        Batch: Spring 2023

                        Digital therapeutics treatment for fear of childbirth

                        Contact person: Annika Järvelin

                        Glue4Life

                        Batch: Spring 2023

                        Next-generation bioinks for 3D bioprinting living tissues and organs.
                        Spin-out to LifeGlue Technologies Oy

                        Contact person: Anni Mörö

                        SanguID

                        Batch: Spring 2023

                        Improved early-stage cancer detection and sensitive disease monitoring
                        Project manager moved to University of Zurich.

                        Contact person: Pyry Helkkula

                        Jedi BF R2B

                        Batch: Fall 2022

                        A smart optical sensor for arthroscopic surgery
                        Preparing spin-out to a startup.

                        Contact person: Isaac Afara

                        Mukava

                        Batch: Fall 2022

                        Graphene based dry electrodes for biometric measurements
                        Spin-out to Mukava Biosignals Oy

                        Contact person: Teemu Ruotsalainen

                        3D CelluGel

                        Batch: Fall 2022

                        A Novel Cell Growth Matrix by 3D Printing of Biopolymers

                        Contact person: Chunlin Xu

                        PAMO

                        Batch: Fall 2021

                        Novel method for diagnosing respiratory suppression
                        Spin-out to a non-published startup.

                        Contact person: Antti Vehkaoja

                        hentoTouch

                        Batch: Fall 2021

                        Non-invasive solution to support rehabilitation from AUD.
                        Spin-out to AlionLife Oy

                        Contact person: Jukka Planman

                        Nosore

                        Batch: Fall 2021

                        Prevention of pressure ulcers
                        Manager was recruited as Team Leader to Attendo.

                        Contact person: Nuno Nobre

                        OrganAnalytics

                        Batch: Fall 2021

                        Viability analysis of organ transplants, and neuronal and cardiac implants
                        Preparing spin-out to a startup.

                        Contact person: Jarno Tanskanen

                        GLOBEVAC

                        Batch: Fall 2021

                        How to make vaccines thermostable
                        Preparing to spin-out a startup.

                        Contact person: Manlio Fusciello

                        3DFluoHisto

                        Batch: Spring 2021

                        Novel method for histology.
                        Solution for commercial use at University of Turku.

                        Contact person: Ilkka Paatero

                        mTMS

                        Batch: Spring 2021

                        mTMS – multilocus transcranial magnetic stimulation.
                        Devices already in use at international pilot customers.

                        Contact person: Dubravko Kicic

                        Corflux

                        Batch: Spring 2021

                        Personalized prediction of the risk for aortic dilatation and rupture.
                        Preparing spin-out to a startup.

                        Contact person: Marja Hedman

                        JasminePro

                        Batch: Spring 2021

                        Poly(jasmine lactone): A Versatile Platform for Drug Delivery

                        Contact person: Kuldeep Bansal

                        MAIJU

                        Batch: 2020

                        Method for objective assessment of infant motor development.
                        Solution in use at BABA Center (HUS) and collaboration with Movesense.

                        Contact person: Sampsa Vanhatalo

                        DecoDerma

                        Batch: 2020

                        Tissue specific therapy for skin diseases.
                        Licensed to THERAVIA.

                        Contact person: Tero Järvinen

                        AccuQT

                        Batch: 2020

                        Accurate correction for QT interval ‒ the most important cardiac risk measure.
                        Spin-out to Monicardi Oy

                        Contact person: Esa Räsänen

                        Moncyte

                        Batch: 2020

                        Functional insight into hypercholesterolemia patients.
                        Spin-out to Moncyte Oy

                        Contact person: Simon Pfisterer

                        PREPARE

                        Batch: Spring 2024

                        Development of powerful protein-based vaccine technologies
                        Spin-out to Innofend Oy

                        Contact person: Minna Hankaniemi

                        ERresQ

                        Batch: Spring 2024

                        Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases.
                        Spin-out to ERresQ Oy

                        Contact person: Vera Kovaleva

                        Solid-IO

                        Batch: Fall 2023

                        Cancer immunotherapy testing on a chip.
                        Spin-out to Solid Immuno-Oncology Oy

                        Contact person: Heidi Haikala

                        OTOS

                        Batch: Spring 2023

                        Early intervention for hearing health
                        Spin-out to Otos Health Oy

                        Contact person: Tanja Tervonen

                        Surgerix

                        Batch: Fall 2022

                        (Former ER4Surgery) Image-guided surgery without Instruments.
                        Spin out to Surgerix Oy.

                        Contact person: Mikko Pitkänen

                        Multivision Diagnostics

                        Batch: Spring 2022

                        Automated and scalable tool for precision diagnosis and personalized treatment
                        Spin-out to MultivisionDx Oy

                        Contact person: Karolina Punovuori

                        AIDHEART

                        Batch: Fall 2021

                        AI for the detection of heart transplant rejection.
                        Product validation continues, spin-out under consideration.

                        Contact person: Juha Peltonen